Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v4-FR
Language English French
Date Updated 2022-05-31 2021-01-27
Drug Identification Number 02329263 02329263
Brand name CHOLETEC CHOLETEC
Common or Proper name MEBROFENIN MEBROFENIN
Company Name BRACCO IMAGING CANADA BRACCO IMAGING CANADA
Ingredients
Strength(s) 45MG 45MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size kit of 10 vials kit of 10 vials
ATC code V09DA V09DA
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-08-25 2020-08-25
Actual start date 2020-08-25 2020-08-25
Estimated end date 2022-03-24 2021-06-18
Actual end date 2022-05-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Disruption of the manufacturing operations at the CMO level related to Covid-19 Disruption of the manufacturing operations at the CMO level related to Covid-19
Health Canada comments